Pharmacodynamic Assessment From a pharmacokinetic standpoint, the two compounds do not share metabolic enzymes
[DOI] [PubMed] [Google Scholar] Caronti B, Antonini G, Calderaro C, Ruggieri S, Palladini G, Pontieri FE, Colosimo C (2001) Dopamine transporter immunoreactivity in peripheral blood lymphocytes in Parkinson's disease
However, the concentration of GSH in these brain areas is maintained in healthy people
Non-GMO and free from unnecessary fillers.
Small amounts of dopamine sulfate can cross the bloodbrain barrier (Suominen et al., 2015), and the levels of the UDP-glucuronosyltransferases and phenol sulfotransferases (needed for dopamine conjugation have been reported in rat and human brain (King et al., 1999